每经AI快讯，海南海药（SZ 000566，收盘价：8.76元）12月23日晚间发布公告称，公司限售股份约1.31 亿股将于2025年12月26日解禁并上市流通，占公司总股本比例为10.08%。 2025年1至6月份，海南海药的营业收入构成为：医药占比78.45%，医疗服务费占比18.6%，其他业务占 比2.95%。 每经头条（nbdtoutiao）——地产"优等生"受困20亿元到期债务，首次债务展期仍在博弈，明年还有超 百亿元公开债到期 （记者 曾健辉） 截至发稿，海南海药市值为114亿元。 ...

每经AI快讯，12月23日，海南海药（000566）(000566.SZ)公告称，公司2016年度非公开发行限售股份 1.31亿股将于2025年12月26日上市流通，占公司总股本的10.08%。 ...

Core Viewpoint - The official launch of the Hainan Free Trade Port's full island customs operation on December 18, 2025, marks a significant milestone in China's reform and opening-up, aiming to create a highly convenient business environment with policies characterized by "one line open, one line controlled, and free movement within the island" [2][5]. Group 1: Strategic Significance - Hainan Free Trade Port construction provides a Chinese solution for global economic cooperation amidst globalization challenges, exploring a system that aligns with international high-standard economic and trade rules [6]. - The design of "one line open, one line controlled" positions Hainan as a "converter" between domestic and international markets, facilitating the introduction of advanced international production factors to support domestic industrial upgrades [7]. - Hainan's development is expected to strengthen regional cooperation with areas like the Guangdong-Hong Kong-Macao Greater Bay Area, enhancing collaboration with inland provinces and creating a new pattern of coordinated development [8]. - Hainan aims to become a source of national innovation by focusing on future industries such as seed industry, deep sea, aerospace, green, and digital economy [9]. Group 2: Policy Benefits - The scope of "zero tariff" has significantly expanded, with the proportion of zero-tariff items increasing from 21% to 74%, covering approximately 6,600 tariff items, which lowers import and operational costs for enterprises [10]. - A "double 15%" tax incentive is available for eligible enterprises and core talents, offering a competitive income tax rate of 15%, alongside visa-free entry for 86 countries [11]. - The increase in duty-free shopping limits and the expansion of duty-free categories enhance consumer access to quality imported goods [12]. - Trade facilitation policies will benefit sectors such as tourism, aviation, logistics, and duty-free industries, marking a shift towards a system-oriented openness in China's economic model [13]. Group 3: Beneficiary Companies - **Duty-Free Consumption**: China Duty Free Group (601888) is expected to benefit directly from the expansion of duty-free policies, with significant revenue contributions from Sanya International Duty-Free City [14]. - **Transportation and Logistics**: Hainan Airport (600515) operates two major international airports, with a high international route coverage, while Hainan Highway (600238) is involved in key infrastructure projects [17][18]. - **Infrastructure and Manufacturing**: Hainan Ruize (002596) anticipates a 25% increase in construction orders due to the customs operation, while Jinpan Technology (688676) benefits from tax incentives and infrastructure projects [19]. - **Healthcare**: Kangzhi Pharmaceutical (300086) is positioned to accelerate the approval of innovative medical products, while Hainan Haiyao (000566) benefits from reduced R&D costs due to zero tariffs [21][22]. - **New Energy and Advanced Manufacturing**: Haima Automobile (000572) is transitioning to new energy vehicles, benefiting from reduced equipment costs and tax incentives [23]. - **Other Specialty Enterprises**: Hainan Rubber (601118) and Hainan Mining (601969) are expected to see growth in exports and resource development opportunities due to the Free Trade Port's establishment [24][25].

证券代码：000566 证券简称：海南海药 公告编号：2025-080 海南海药股份有限公司 关于 2016 年度非公开发行限售股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 1、本次解除限售股份数量为 130,825,900 股，占公司股份总数的 10.08%。 2、本次解除限售股份可上市流通日期为 2025 年 12 月 26 日。 一、本次解除限售股份的基本情况及公司股本变化情况 （一）本次解除限售股份的基本情况 经中国证券监督管理委员会《关于核准海南海药股份有限公司非公开发行股票的批 复》（证监许可[2016]1353号）核准，海南海药股份有限公司（以下简称"公司"）非 公开发行245,298,400股人民币普通股（A股），发行价格为12.23元/股，于2016年9月12 日在深圳证券交易所上市，本次非公开发行股票完成后，公司总股本由 1,090,680,864 股增加至 1,335,979,264 股。其中，本次非公开发行股票深圳市南方同正投资有限公司 （以下简称"南方同正"）获配股数130,825,900股，限 ...

国海证券股份有限公司 关于海南海药股份有限公司 非公开发行股票限售股解除限售上市流通的核查意见 国海证券股份有限公司（以下简称"国海证券"或"保荐人"）作为海南海 药股份有限公司（以下简称"海南海药"、"上市公司"或"公司"）非公开发 行 A 股股票的保荐人，根据《证券发行上市保荐业务管理办法》、《深圳证券 交易所股票上市规则》、《深圳证券交易所上市公司自律监管指引第 1 号—主 板上市公司规范运作》等相关法律、法规和规范性文件的规定，对海南海药非公 开发行股票限售股解除限售上市流通的事项进行了审慎核查，具体核查情况如下： 一、本次解除限售股份取得的情况 （一）本次解除限售股份的基本情况 经中国证券监督管理委员会《关于核准海南海药股份有限公司非公开发行股 票的批复》（证监许可[2016]1353 号）核准，海南海药非公开发行 245,298,400 股人民币普通股（A 股），发行价格为 12.23 元/股，于 2016 年 9 月 12 日在深圳 证券交易所上市，本次非公开发行股票完成后，公司总股本由 1,090,680,864 股 增加至 1,335,979,264 股。其中，本次非公开发行股票深圳市南方同 ...

Core Viewpoint - The Hainan Free Trade Zone index in the A-share market has seen a significant rise for three consecutive days, reaching a historical high, driven by strong performances from various stocks in the sector [1] Group 1: Market Performance - The Hainan Free Trade Zone index has increased for three consecutive days, achieving a historical high [1] - Notable stock performances include: - Shennong Agricultural (神农种业) up over 18% - Kangzhi Pharmaceutical (康芝药业) up over 13% - Antong Holdings (安通控股), Hainan Haiyao (海南海药), Hainan Development (海南发展) all hitting the daily limit up of 10% [1] - Other stocks such as Haikou Group (海汽集团) and Hainan Ruize (海南瑞泽) also showed strong gains, with increases ranging from 5% to 8% [1][2] Group 2: Sales Performance - On December 18, the first day of customs closure, Sanya's total duty-free sales reached 118 million yuan [1] - On December 19, daily sales from duty-free shops in Sanya reached 105 million yuan, marking a year-on-year increase of 45.8% [1] - On December 20, sales were recorded at 108 million yuan, reflecting a year-on-year growth of 47% [1] Group 3: Future Opportunities - According to Industrial Securities, the Hainan Free Trade Port aims to establish a new regional offshore international trade center, presenting multiple development opportunities [1] - Key areas of focus include: - Deepening cooperation between Hainan and Hong Kong, setting a model for collaboration between Hong Kong and mainland provinces [1] - Promoting high-end manufacturing by leveraging policies such as "zero tariffs" and "processing value-added tax exemptions" to invigorate the manufacturing economy [1] - Upgrading new consumption patterns, with optimized duty-free policies enhancing the attractiveness of the "duty-free + entertainment" model [1]

海南海药今日涨停，全天换手率29.43%，成交额29.66亿元，振幅4.29%。龙虎榜数据显示，机构净买入 1.28亿元，深股通净买入1.30亿元，营业部席位合计净卖出1672.42万元。 深交所公开信息显示，当日该股因日涨幅偏离值达10.02%上榜，机构专用席位净买入1.28亿元，深股通 净买入1.30亿元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交6.90亿元，其中，买入成交额为4.65亿 元，卖出成交额为2.25亿元，合计净买入2.41亿元。 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 深股通专用 | 19529.33 | 6564.83 | | 买二 | 机构专用 | 7509.36 | 4758.72 | | 买三 | 机构专用 | 7268.61 | 1843.52 | | 买四 | 国盛证券有限责任公司上海浦东新区世纪大道证券营业 | 5358.82 | 870.74 | | | 部 | | | | 买五 | 机构专用 | 4949.48 | 348.9 ...

海南海药股份有限公司（以下简称"公司"）（股票简称：海南海药，股票 代码：000566）股票于 2025 年 12 月 19 日、12 月 22 日、12 月 23 日连续 3 个 交易日收盘价格涨幅偏离值累计达到 20%以上。根据深圳证券交易所（以下简称 "深交所"）的有关规定，属于股票交易异常波动情况。 证券代码：000566 证券简称：海南海药 公告编号：2025-081 海南海药股份有限公司 关于股票交易异常波动公告 本公司董事会及全体董事保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、股票交易异常波动的情况介绍 二、公司关注并核实的相关情况 针对公司股票交易异常波动情况，公司对有关事项进行了核查，并询问了公 司控股股东和实际控制人，现将相关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处。 2、公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生 较大影响的未公开重大信息。 3、公司近期经营情况正常及内外部经营环境未发生重大变化。 4、公司、控股股东和实际控制人不存在关于本公司的应披露而未披露的重 大事项，或处于筹划阶段的重大事项； 本公司董事会 ...

海南海药（维权）(000566.SZ)今日涨停3连板，换手率29.43%，成交额29.66亿元。龙虎榜数据显示，深股通买入2.77亿元，卖出1.04亿元，净买入1.73亿 元；三家机构买入1.97亿元，卖出6951万元，净买入1.28亿元。上榜席位全天买入7.62亿元，卖出3.51亿元，合计净买入4.11亿元。(格隆汇) | 序号 | 交易营业部名称 | | 买入金额(万) | 占息成交比例 | | --- | --- | --- | --- | --- | | 1 | 深股通专用 | 686次 44.31% 2 | 27716.37 | 5.32% | | 2 | 机构专用 | 1567次 41.10% | 14383.89 | 2.76% | | 3 | 东方财富证券股份有限公司拉萨团结路第一证券营业部 | 511次 32.49% | 3439.78 | 0.66% | | 4 | 国信证券股份有限公司浙江互联网分公司 | 422次 32.94% | 4484.52 | 0.86% | | 5 | 东方财富证券股份有限公司拉萨金融城南环路证券营业部 | 459次 33.33% | 3482.65 | 0. ...

证券日报网讯 12月23日，海南海药在互动平台回答投资者提问时表示，截至2025年12月10日，公司股 东户数为144826户。公司将积极挖掘海南自贸港及海南博鳌乐城国际医疗旅游先行区政策资源优势，努 力开拓公司新渠道、探索新模式、实现新增长，如有进展公司将根据相关规定及时披露。 （文章来源：证券日报） ...